Resolve Biosciences provides a Molecular Cartography platform, which is a multi-analyte, highly multiplex spatial analysis technology for resolving complex biological challenges in areas such as oncology, neuroscience, and infectious disease.

Resolve Biosciences

Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program. 

PS Capital

HTGF | High-Tech Gruenderfonds

John Shoffner

EDBI

Alafi Capital

NRW.BANK

Patient Square Capital

Are you facing a dilemma in choosing between an imaging or sequencing-based spatial approach for your research? Your solution awaits. This exceptional review paper provides a comprehensive breakdown of the technical differences between these two platforms and their research implications. 

https://lnkd.in/eq5JwTQz

#lifesciences #neuroscience #singlecell

Ready to revolutionize spatial biology? Resolve Biosciences is hunting for motivated Application Development Scientists and Technicians to join our team in Natick, MA. If you have a chemical biology, immunology, or molecular pathology background, consider joining us in driving the future of multi-omic spatial platforms.  Apply now at the link. 🧬 https://lnkd.in/gTECgyNN

We’re thrilled to share the recent study, "Multimodal decoding of human liver regeneration," in which researchers discovered a novel ANXA2+ migratory hepatocyte subpopulation and gained crucial insights into liver regeneration dynamics.

Our high-resolution spatial analysis technology, Molecular Cartography, was utilized in the research, helping pave the way for new therapies in regenerative medicine. Congratulations on the publication to all involved! 

#biotech #research #spatialbiology
Read more: https://lnkd.in/eszJ6JWZ

We want to take a moment to shine a spotlight on our outstanding team at Resolve Biosciences. From Monheim, Germany to Natick, Massachusetts - our team's expertise and dedication is the foundation of our success. Thank you, Resolvers, for your invaluable contributions!

#teamappreciation #biotech #international

Just another day of making content in the lab! 

Shoutout to Matthew Graham, Field Application Scientist, for joining the Monheim-based Marketing team to shoot some new visual media projects. Stay tuned to see what we filmed... 

#behindthescences #contentcreation #marketing  #biotech

Metric
Company Name	Resolve Biosciences
Symbol
MSH ID	COM:RESOLVEBIOSCIENCES
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	DE
Stage
Employee Count	99
Website	resolvebiosciences.com
LinkedIn	resolve-biosciences
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

RESO

COM:RESOLVEBIOSCIENCES

Resolve Biosciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue